Acting Director of the White House Office of National Drug Control Policy, Regina LaBelle, discusses the Biden-Harris Administration’s strategy for addressing the overdose crisis and the role of litigation in addressing addiction and the overdose epidemic while advancing equity. This keynote address is part of the O’Neill Institute’s Opioid Litigation Summit.